MEDLIVE (02192.HK): Adopts Revised Dividend Policy, Pledges 80% Payout

On 18 November 2026, MEDLIVE (02192.HK) adopted a revised dividend policy, pledging to pay at least 80% of attributable profit each year during 2026-2028.

NewTimeSpace News: On 18 November 2026, Medlive Technology Co., Ltd. (stock code: 02192) announced that its board has approved and adopted a revised dividend policy, replacing the existing policy set out on page 112 of the 2025 annual report published on 21 April 2026, with effect from 18 November 2026.

Under the revised policy, for the three financial years ending 31 December 2026, 2027 and 2028, the company plans to distribute dividends, comprising both final and interim dividends, of no less than 80% of the profit attributable to owners of the parent for the relevant year.

The policy was prepared in accordance with the relevant provisions of the company's articles of association. The company aims to maximise shareholder returns and may declare dividends payable in any currency to shareholders from time to time, provided that no dividend may exceed the amount recommended by the board and no dividend may be declared except out of profits and reserves legally available for distribution. Dividends may be distributed in cash or in such other manner as the board considers appropriate, based on factors including operating results, cash flow, financial position, shareholder interests, capital requirements and cash dividends received from subsidiaries.

Dividend payments are subject to applicable laws and regulations, including Cayman Islands law and the company's articles of association. The board will review the policy from time to time in light of operating needs, earnings, financial position, working capital requirements and future business plans, and may update, revise or change it at any time. The company gives no assurance that any specific amount of dividend will be paid in any particular period.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.